Ryan D. Chavez
Plus aucun poste en cours
Historique de carrière de Ryan D. Chavez
Anciens postes connus de Ryan D. Chavez
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Directeur Financier/CFO | 17/11/2016 | 01/03/2019 |
Conseiller Juridique Général | 18/07/2016 | 01/03/2019 | |
Secrétaire Général | 18/07/2016 | 01/03/2019 | |
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
MALLINCKRODT PLC | Conseiller Juridique Général | - | - |
Rutan & Tucker LLP
Rutan & Tucker LLP Miscellaneous Commercial ServicesCommercial Services Rutan & Tucker LLP provides legal services. It offers corporate and tax, employment, intellectual property, litigation and trial, and real estate services. The company was founded in 1986 and is headquartered in Costa Mesa, CA. | Corporate Officer/Principal | 02/05/2011 | - |
Formation de Ryan D. Chavez
Chapman University | Graduate Degree |
Stanford University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Irlande | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
General Counsel | 2 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MALLINCKRODT PLC | Health Technology |
Entreprise privées | 3 |
---|---|
Rutan & Tucker LLP
Rutan & Tucker LLP Miscellaneous Commercial ServicesCommercial Services Rutan & Tucker LLP provides legal services. It offers corporate and tax, employment, intellectual property, litigation and trial, and real estate services. The company was founded in 1986 and is headquartered in Costa Mesa, CA. | Commercial Services |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
- Bourse
- Insiders
- Ryan D. Chavez
- Expérience